Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Stanford researcher Genovese joins Gilead to lead NASH, arthritis programs
Fierce Biotech
Tue, 06/2/20 - 10:46 am
Gilead Sciences
Mark Genovese
NASH
arthritis
Gilead’s remdesivir shows some benefit in patients with moderate Covid-19, new data show
Stat
Mon, 06/1/20 - 10:32 am
Gilead Sciences
remdesivir
COVID-19
Gilead trumpets data with newly-bought magrolimab in blood cancers
Pharmaforum
Sun, 05/31/20 - 11:53 pm
Gilead Sciences
ASCO 2020
Forty Seven
magrolimab
M&A
MDS
Gilead’s newly bought immunotherapy drug scores at ASCO
MedCity News
Fri, 05/29/20 - 12:30 pm
Gilead Sciences
ASCO 2020
magrolimab
clinical trials
AML
MDS
Roche and Gilead Launch COVID-19 Trial to Test One-Two Punch of Actemra and Remdesivir
BioSpace
Thu, 05/28/20 - 10:59 pm
Roche
Gilead Sciences
clinical trials
Actemra
RoActemra
remdesivir
COVID-19
pneumonia
COVID-19 pneumonia
UK grants early access for Gilead’s remdesivir in Covid-19
MedCity News
Thu, 05/28/20 - 10:37 am
UK
Gilead Sciences
remdesivir
COVID-19
Gilead pens $2B Arcus pact for immuno-oncology targets of the past and future
Fierce Biotech
Wed, 05/27/20 - 10:28 am
Gilead Sciences
ARCUS
immuno-oncology
Bangladesh pharma claims to be first to launch generic remdesivir
BioPharma Dive
Thu, 05/21/20 - 11:08 pm
Bangladesh
Beximco
generics
remdesivir
Gilead Sciences
COVID-19
Gilead's filgotinib phase 3 hits primary endpoint but details dampen hopes
Fierce Biotech
Thu, 05/21/20 - 10:28 am
Gilead Sciences
Galapagos
filgotinib
ulcerative colitis
clinical trials
Covid-19 has exposed the limits of the pharmaceutical market model
Stat
Wed, 05/20/20 - 11:26 pm
pharma marketing
Gilead Sciences
remdesivir
COVID-19
drug development
pandemics
Big pharma heads towards important readouts
EP Vantage
Wed, 05/20/20 - 10:22 am
Ozempic
Novo Nordisk
etrolizumab
Roche
Ipatasertib
finerenone
Bayer
filgotinib
Gilead Sciences
Galapagos
Avalglucosidase alfa
Sanofi
Rinvoq
AbbVie
clinical trials
GSK sub’s injectable outperforms Gilead in late-stage PrEP trial
Endpoints
Tue, 05/19/20 - 10:33 am
GSK
Gilead Sciences
HIV
PrEP
Truvada
ViiV Healthcare
cabotegravir
Gilead ups its donation of the Covid-19 drug remdesivir for U.S. hospitals
Stat
Mon, 05/18/20 - 11:09 pm
Gilead Sciences
COVID-19
remdesivir
federal government
More threat to Gilead's HIV business? GlaxoSmithKline touts long-acting injectable PrEP win against Truvada
Fierce Pharma
Mon, 05/18/20 - 11:12 am
GSK
Gilead Sciences
Truvada
cabotegravir
HIV
PrEP
Why Gilead's Remdesivir Might Not Be the Mega-Moneymaker Some Think It Will Be
Motley Fool
Mon, 05/18/20 - 11:10 am
Gilead Sciences
remdesivir
COVID-19
Where Will Gilead Sciences Be in 1 Year?
Motley Fool
Wed, 05/13/20 - 11:15 am
Gilead Sciences
remdesivir
COVID-19
pandemic
Gilead inks deals with generics makers to supply COVID-19 therapy remdesivir for 127 countries
Fierce Pharma
Tue, 05/12/20 - 05:16 pm
Gilead Sciences
generics
drug manufacturing
COVID-19
remdesivir
With little data, doctors struggle to decide which Covid-19 patients should get remdesivir
Stat
Tue, 05/12/20 - 12:05 pm
Gilead Sciences
remdesivir
physicians
pandemic
patients
COVID-19
Inside the NIH’s controversial decision to stop its big remdesivir study
Stat
Mon, 05/11/20 - 10:24 am
Gilead Sciences
remdesivir
NIH
clinical trials
COVID-19
pandemic
Trump administration: States to decide which hospitals gets Gilead's COVID-19 drug
BioPharma Dive
Mon, 05/11/20 - 10:12 am
Donald Trump
pandemic
Gilead Sciences
remdesivir
COVID-19
Pages
« first
‹ previous
…
15
16
17
18
19
20
21
22
23
…
next ›
last »